Materiały źródłowe

• #1 Esophageal Cancer Awareness & Prevention Resources | CDx Diagnostics

  https://www.cdxdiagnostics.com/patient-resources

  More than 25 million Americans experience daily heartburn which can lead to a condition called Barretts esophagus. […] Barretts esophagus increases the risk of developing esophageal cancer by 50 times or more. […] Due to recent advances in detection, your doctor can better help ensure that if any precancerous cells are present, they will be identified and then treated to prevent their progression to Esophageal Adenocarcinomaone of the fastest growing cancers in America. […] Doctors believe most cases of adenocarcinoma of the esophagus begin in Barretts tissue. […] There are some experimental treatments in which the Barretts tissue can be destroyed through the endoscope, but these treatments can cause complications, and their effectiveness in preventing cancer is unclear. […] The risk of esophageal cancer in patients with Barretts esophagus is quite low, approximately 0.5 percent per year (or 1 out of 200). Therefore, the diagnosis of Barretts esophagus should not be a reason for alarm. It is, however, a reason for periodic endoscopies.

• #2 Molecular Abnormalities and Carcinogenesis in Barrett’s Esophagus: Implications for Cancer Treatment and Prevention

  https://www.mdpi.com/2073-4425/16/3/270

  Barrett’s esophagus (BE) is described by the transformation of the normal squamous epithelium into metaplastic columnar epithelium, driven by chronic gastroesophageal reflux disease (GERD). […] Understanding the molecular mechanisms underlying BE carcinogenesis is crucial for improving prevention, surveillance, and treatment strategies. […] Innovations in chemoprevention, such as combining proton pump inhibitors and aspirin, and the potential of antireflux surgery to halt disease progression are promising. […] A deeper understanding of its molecular transformation can enhance surveillance protocols, optimize the management of gastroesophageal reflux inflammation, and refine prevention and therapeutic strategies, ultimately contributing to a reduction in the global burden of EAC. […] Chemoprevention emerges as a promising area in preventing carcinogenesis in BE. The randomized AspECT trial demonstrated that a combination of high-dose proton pump inhibitors (PPIs) and aspirin significantly delayed the development of EAC and high-grade dysplasia in BE patients.

• #3 Barrett’s Esophagus is fully preventable and treatable. The Heartburn Center of South Texas has treatment options.

  https://heartburnmd.com/barretts-esophagus-prevention-treatment/

  Barrett’s Esophagus is fully preventable and treatable. […] The treatment for Barrett’s Esophagus has been compared to the preventive treatment of colon cancer. […] Regular monitoring for patients with Barrett’s Esophagus is so important because steps can be taken to prevent the progression to cancer. […] There are steps you can take to avoid acid reflux. These include not eating right before bedtime, avoiding tobacco, avoiding acid-producing foods, eating smaller meals, and losing weight if you are overweight. […] Your doctor may have prescribed medication to reduce acid. These medications reduce the amount of acid in the esophagus, thereby reducing symptoms of heartburn. However, no scientific evidence suggests that taking these medications will prevent the development of esophageal dysplasia or cancer.

• #4 Barrett’s Esophagus: Understanding Risks and Effective Prevention Strategies — Gastro Florida

  https://gastrofl.com/barretts-esophagus-understanding-risks-and-effective-prevention-strategies/

  Barrett’s esophagus is a condition where the lining of the esophagus is damaged by stomach acid, often due to chronic acid reflux or GERD. Understanding its risks and implementing preventive measures is crucial in managing this condition. […] Lifestyle changes play a significant role in preventing Barrett’s esophagus. This includes managing acid reflux through diet, avoiding tobacco and excessive alcohol, maintaining a healthy weight, and elevating the head while sleeping. Eating a balanced diet rich in fruits and vegetables can also reduce the risk of developing esophageal cancer. Regular exercise is also crucial in maintaining overall health and reducing the risk of obesity-related conditions. […] A diet low in acidic foods and high in fruits, vegetables, and whole grains can help manage symptoms and reduce the risk of Barrett’s esophagus. Avoiding large meals and eating well before bedtime are also recommended.

• #5 Lifestyle Changes for Barrett’s Esophagus | NYU Langone Health

  https://nyulangone.org/conditions/barretts-esophagus/treatments/lifestyle-changes-for-barrett-s-esophagus

  People with Barretts esophagus who smoke have a higher risk of developing esophageal cancer than those who dont. […] Smoking can also decrease the production of saliva, which neutralizes acid. […] If you are overweight or obese, your doctor can refer you to specialists and nutritionists in the NYU Langone Weight Management Program who can help you lose weight.

• #6 Barrett’s Esophagus: Symptoms & Causes | NewYork-Presbyterian

  https://www.nyp.org/digestive/esophageal-diseases/barretts-esophagus

  As Barretts esophagus can appear in patients with no history of acid reflux, doctors recommend screening patients with chronic GERD. […] Other preventative measures to hinder the development of Barretts esophagus are: […] Quitting smoking. Smoking irritates can damage the esophageal tissue, causing the cells to protect themselves by changing their properties. […] Maintaining a healthy weight. Having extra fat around the abdomen squeezes your stomach, causing more fluid to travel upward into your esophagus. This makes it more likely you will experience stomach acid leakage and GERD, causing damage to the esophageal lining. […] Taking a proton pump inhibitor. This is recommended for all Barretts patients, regardless of symptoms. Data supports that PPIs lower the risk of eAC in Barretts patients.

• #7 Lifestyle interventions can reduce the risk of Barrett’s esophagus: a systematic review and meta‐analysis of 62 studies involving 250,157 participants

  https://pmc.ncbi.nlm.nih.gov/articles/PMC8335822/

  Lifestyle modifications could reduce the risks of Barrett’s esophagus (BE) and, consequently, esophageal adenocarcinoma. […] We found that smoking, alcohol intake, high levels of body fatness, and less sleep time are associated with Barrett’s esophagus risk. There are statistically significant reduced risks of Barrett’s esophagus with aspirin use and vitamin C intake, folate, and dietary fiber. […] Our analyses demonstrated a significantly increased BE risk associated with smoking, alcohol intake, high BMI, less sleep time, and PPI use. Inversed associations were observed with aspirin use, vitamin C intake, and dietary fiber intake. […] The results demonstrated that smoking is associated with Barrett’s esophagus risk. […] A significant 23% increased risk was observed for highest versus lowest alcohol intake and BE risk.

• #8 What Should I Know about Barrett’s Esophagus and Risk for Esophageal Cancer? | Memorial Sloan Kettering Cancer Center

  https://www.mskcc.org/news/what-should-know-about-barrett-s-esophagus-and-risk-esophageal

  Some people may want to try limiting coffee, mint, and chocolate, as they can be triggering for reflux, Ms. Stella says. Also, limiting alcohol may decrease gastric acidity, and alcohol consumption is a well-known risk factor for all cancers. […] Because Barretts esophagus is related to GERD, its very important that patients with Barretts be treated for GERD with medications or procedures that alleviate the condition, even if they arent experiencing symptoms.

• #9 Barrett’s Esophagus: Symptoms & Causes | NewYork-Presbyterian

  https://www.nyp.org/digestive/esophageal-diseases/barretts-esophagus

  As Barretts esophagus can appear in patients with no history of acid reflux, doctors recommend screening patients with chronic GERD. […] Other preventative measures to hinder the development of Barretts esophagus are: […] Quitting smoking. Smoking irritates can damage the esophageal tissue, causing the cells to protect themselves by changing their properties. […] Maintaining a healthy weight. Having extra fat around the abdomen squeezes your stomach, causing more fluid to travel upward into your esophagus. This makes it more likely you will experience stomach acid leakage and GERD, causing damage to the esophageal lining. […] Taking a proton pump inhibitor. This is recommended for all Barretts patients, regardless of symptoms. Data supports that PPIs lower the risk of eAC in Barretts patients.

• #10 Preventing Esophageal Cancer | NYU Langone Health

  https://nyulangone.org/conditions/esophageal-cancer/prevention

  If you are overweight or obese, talk with your doctor or a dietitian about the best way to slim down. […] Being obese can contribute to GERD, because excess abdominal weight may push acid into the esophagus, which increases your risk of developing esophageal cancer. […] Eating a diet rich in fruits and vegetables may help you lose weight. […] Infection with certain types of human papillomavirus, or HPV, a common sexually transmitted disease, can increase your chance of developing squamous cell cancer. […] Achalasia is a rare disorder in which the muscles in the lower esophagus that are required to move food into your stomach gradually stop contracting. […] People with achalasia have an increased long-term risk of developing esophageal cancer.

• #11 Lifestyle Changes for Barrett’s Esophagus | NYU Langone Health

  https://nyulangone.org/conditions/barretts-esophagus/treatments/lifestyle-changes-for-barrett-s-esophagus

  Barretts esophagus, a condition in which the tissue that lines the esophagus becomes precancerous, is not reversible. However, there are effective ways to manage gastroesophageal reflux disease, or GERD, a condition doctors believe is associated with Barretts esophagus. Lifestyle changes can help reduce the risk of Barretts esophagus progressing to cancer. […] NYU Langone gastroenterologists may recommend lifestyle changes in combination with medication or other treatments, such as endoscopic procedures. […] Avoiding trigger foodssuch as chocolate, coffee, fried foods, peppermint, spicy foods, and carbonated beveragescan help reduce symptoms. […] Doctors also recommend eating multiple small, frequent meals instead of a few large ones. […] In addition, research suggests that drinking alcohol may increase the risk of GERD and Barretts esophagus. Our doctors recommend avoiding alcohol altogether if you have been diagnosed with either condition.

• #12 Barrett’s Esophagus Diet: Foods to Eat and Foods to Avoid

  https://www.healthline.com/health/barretts-esophagus-diet

  Lifestyle factors that help you control acid reflux may also help maintain Barrett’s esophagus and reduce the risk of cancer. Avoid these factors if you have acid reflux or Barrett’s esophagus: eating late at night, eating three large meals instead of small, frequent meals, taking blood-thinning medications such as aspirin (Bufferin), lying flat while sleeping. […] If you have Barrett’s esophagus, changes to your diet and lifestyle can help keep this condition in check and prevent cancers of the esophagus.

• #13 What Should I Know about Barrett’s Esophagus and Risk for Esophageal Cancer? | Memorial Sloan Kettering Cancer Center

  https://www.mskcc.org/news/what-should-know-about-barrett-s-esophagus-and-risk-esophageal

  Barretts esophagus should be closely monitored, and in some cases treated, to reduce this risk. […] The most important step is to reduce and minimize acid reflux. Effective ways to do this include: lose weight if you are overweight and obese, dont smoke, limit alcohol consumption, eat smaller meals, and wait a few hours before going to bed, avoid late-night snacking, sleep with your head slightly elevated (nighttime GERD is more damaging because the esophagus is also sleeping and does not promptly push acid down). […] Working with a dietitian and the primary care team on weight management is a very important lifestyle step that patients can take to reduce their risk, she says. […] Changing your diet can make a big difference in preventing acid reflux. […] Overall, focusing on more fruits and vegetables in the diet is the best approach to avoiding not just GERD and Barretts esophagus, but all forms of chronic disease, she adds.

• #14 Acid reflux, Barrett’s esophagus and esophageal cancer: What’s the link? | MD Anderson Cancer Center

  https://www.mdanderson.org/cancerwise/acid-reflux–barretts-esophagus-and-esophageal-cancer–what-is-the-link.h00-159387468.html

  You can reduce your risk for Barretts esophagus if you avoid the long-term inflammation caused by acid reflux. […] That means watching your diet, as well as when and how much food you eat. […] Eating a heavy meal with a lot of fried food, drinking alcohol with dinner and then going to bed on a full stomach — that’s reflux city, says Hofstetter. Smoking also increases the risk of Barretts esophagus. […] To avoid acid reflux: Avoid tobacco and alcohol […] Eat a plant-based diet […] Don’t eat too close to bedtime and keep evening meals light […] Maintain a healthy weight […] Watch out for reflux triggers like caffeine or peppermint. […] Even though the risk for esophageal cancer from Barretts esophagus is low, its still important to do all you can to embrace a healthy lifestyle.

• #15 What Should I Know about Barrett’s Esophagus and Risk for Esophageal Cancer? | Memorial Sloan Kettering Cancer Center

  https://www.mskcc.org/news/what-should-know-about-barrett-s-esophagus-and-risk-esophageal

  Barretts esophagus should be closely monitored, and in some cases treated, to reduce this risk. […] The most important step is to reduce and minimize acid reflux. Effective ways to do this include: lose weight if you are overweight and obese, dont smoke, limit alcohol consumption, eat smaller meals, and wait a few hours before going to bed, avoid late-night snacking, sleep with your head slightly elevated (nighttime GERD is more damaging because the esophagus is also sleeping and does not promptly push acid down). […] Working with a dietitian and the primary care team on weight management is a very important lifestyle step that patients can take to reduce their risk, she says. […] Changing your diet can make a big difference in preventing acid reflux. […] Overall, focusing on more fruits and vegetables in the diet is the best approach to avoiding not just GERD and Barretts esophagus, but all forms of chronic disease, she adds.

• #16 Barrett’s Esophagus Diet: Foods to Eat and Foods to Avoid

  https://www.healthline.com/health/barretts-esophagus-diet

  Eating certain foods, including those containing fiber, while avoiding sugary foods and those that cause heartburn may help prevent Barrett’s esophagus from getting worse. […] Getting plenty of fiber in your daily diet is good for your overall health. Medical research shows that it may also help prevent Barrett’s esophagus from worsening and lower your risk of cancer in the esophagus. […] A 2017 clinical study found that eating too many refined sugary foods may increase the risk of Barrett’s esophagus. […] Controlling your acid reflux with diet and other treatment may help to prevent Barrett’s esophagus from getting worse. […] There are several lifestyle changes you can make to help prevent cancers of the esophagus. This is especially important if you have Barrett’s esophagus. Healthy changes that prevent acid reflux and other factors that irritate the lining of the esophagus may keep this condition under control.

• #17 Diagnosis and Management of Barrett’s Esophagus

  https://www.mdpi.com/2077-0383/12/6/2141

  Dietary fiber intake was inversely associated with the risk of Barrett’s esophagus and esophageal cancer; however, this meta-analysis should be treated with caution, considering the limited number of studies included and their heterogeneity. […] Lifestyle changes were proven to reduce the risk of BE as well as GERD. […] Smoking is associated with an increased risk of BE. […] The use of proton pump inhibitors (PPI) could be another potential defense against progressing from BE to HGD or EAC. […] NSAIDs, particularly aspirin, were associated with a reduced risk of BE. […] Other drugs associated with a reduction in BE progression to EAC are vitamin D or supplemental calcium. […] Zhang et al. demonstrated that acidic bile salts can induce epithelial-to-mesenchymal transition (EMT) of Barrett’s cells.

• #18 Current management of Barrett esophagus and esophageal adenocarcinoma | Cleveland Clinic Journal of Medicine

  https://www.ccjm.org/content/86/11/724

  The recommended treatment of dysplasia is endoscopic eradication followed by surveillance endoscopy. […] Chemoprevention is an exciting area of research in preventing progression to adenocarcinoma in patients with Barrett esophagus. […] Aspirin has been shown to prevent development of Barrett esophagus in patients with reflux disease, but more studies are needed to validate those findings. […] Gastroesophageal reflux disease is a primary risk factor for esophageal adenocarcinoma, and gastric acid suppression with PPIs reduces cancer risk. […] PPI therapy is associated with a 71% decrease in the risk of high-grade dysplasia and adenocarcinoma in patients with Barrett esophagus. […] Statins appear promising for chemoprevention, but more study is needed. […] Chemoprevention may be considered in patients with Barrett esophagus and multiple risk factors for adenocarcinoma.

• #19 The future of therapy of Barrett’s esophagus and related cancer: a narrative review – Pilonis – Annals of Esophagus

  https://aoe.amegroups.org/article/view/6025/html

  Barretts esophagus (BE) is an intestinal-type metaplastic condition of the esophagus, which occurs in response to severe inflammation generally as result of chronic gastro-esophageal reflux. […] The treatment algorithm for BE has seen dramatic changes in the last 10 years thanks to the better understanding of the natural history of dysplasia and early EAC and to the advent of effective endoscopic ablation techniques. […] There is growing need to combine technological advances with early diagnosis and targeted pharmacological treatments in order to refine management strategies. This would ideally entail early intervention on patients with a high probability to progress to cancer and minimally invasive treatment in patients with cancer at low metastatic risk. […] It is therefore intuitive that pharmacological control of reflux through proton pump inhibitors (PPI), that suppress gastric acid production, may reduce the risk of cancer. A meta-analysis correlated current PPI treatment with a 71% cancer risk reduction.

• #20

  https://link.springer.com/article/10.1007/s10620-018-5149-6

  Barretts esophagus is common in Western countries, but progression to esophageal adenocarcinoma is uncommon. […] Most evidence regarding the potential benefit of chemoprevention of Barretts esophagus and prevention of progression to esophageal adenocarcinoma is based on observational studies such as casecontrol and cohort studies. […] Given the potential benefits and relatively low risks, patients with BE should receive once-daily PPI therapy, but routine use of twice-daily PPI is not recommended unless necessitated by poor control of reflux symptoms or esophagitis. […] Recent data suggest that the inverse associations between aspirin/NSAID use and esophageal adenocarcinoma may be the result of reducing neoplastic progression (from metaplasia to dysplasia and carcinoma) rather than initiation of Barretts esophagus.

• #21 Lifestyle interventions can reduce the risk of Barrett’s esophagus: a systematic review and meta‐analysis of 62 studies involving 250,157 participants

  https://pmc.ncbi.nlm.nih.gov/articles/PMC8335822/

  Lifestyle modifications could reduce the risks of Barrett’s esophagus (BE) and, consequently, esophageal adenocarcinoma. […] We found that smoking, alcohol intake, high levels of body fatness, and less sleep time are associated with Barrett’s esophagus risk. There are statistically significant reduced risks of Barrett’s esophagus with aspirin use and vitamin C intake, folate, and dietary fiber. […] Our analyses demonstrated a significantly increased BE risk associated with smoking, alcohol intake, high BMI, less sleep time, and PPI use. Inversed associations were observed with aspirin use, vitamin C intake, and dietary fiber intake. […] The results demonstrated that smoking is associated with Barrett’s esophagus risk. […] A significant 23% increased risk was observed for highest versus lowest alcohol intake and BE risk.

• #22 The future of therapy of Barrett’s esophagus and related cancer: a narrative review – Pilonis – Annals of Esophagus

  https://aoe.amegroups.org/article/view/6025/html

  In keeping with the primary role of inflammation in the etiopathogenesis of BE related neoplasia, use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) has been shown to reduce the incidence of gross DNA abnormalities as well as point mutation linked to cancer development. […] Statins represent another interesting class of drug which might interfere with the cancer development in BE. […] Considering that BE is associated with obesity and metabolic syndrome, it is possible to envisage that in the future a combination of PPI with statins and aspirin, which also reduces the cardiovascular risk, might be the preferred pharmacological treatment of patients with BE. […] An optimal solution would be to limit the treatment to those patients at highest risk to progress to cancer.

• #23 The future of therapy of Barrett’s esophagus and related cancer: a narrative review – Pilonis – Annals of Esophagus

  https://aoe.amegroups.org/article/view/6025/html

  In keeping with the primary role of inflammation in the etiopathogenesis of BE related neoplasia, use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) has been shown to reduce the incidence of gross DNA abnormalities as well as point mutation linked to cancer development. […] Statins represent another interesting class of drug which might interfere with the cancer development in BE. […] Considering that BE is associated with obesity and metabolic syndrome, it is possible to envisage that in the future a combination of PPI with statins and aspirin, which also reduces the cardiovascular risk, might be the preferred pharmacological treatment of patients with BE. […] An optimal solution would be to limit the treatment to those patients at highest risk to progress to cancer.

• #24

  https://link.springer.com/article/10.1007/s10620-018-5149-6

  While substantial associative data suggest a potential benefit of aspirin and nonaspirin NSAIDs in reducing the risk of progression of Barretts esophagus, the low risk of progression and the potential risks (gastrointestinal bleeding, complicated ulcer disease, hemorrhagic stroke) do not warrant routine use, unless dictated by cardiovascular risk. […] Chemoprevention after mucosal ablation in those at highest risk of post-ablation recurrence (dysplastic Barretts) is currently under investigation.

• #25 National Institute for Health and Care Excellence (NICE) guidance on monitoring and management of Barrett’s oesophagus and stage I oesophageal adenocarcinoma | Gut

  https://gut.bmj.com/content/73/6/897

  1.2.2 Do not offer aspirin to people with Barretts oesophagus to prevent progression to oesophageal dysplasia and cancer. […] 1.8.1 Do not offer anti-reflux surgery to people with Barretts oesophagus to prevent progression to dysplasia or cancer. […] The committee agreed that anti-reflux surgery does not offer any advantage over medical treatment with PPIs for progression to dysplasia or cancer. Therefore, the committee agreed, based on the current limited and low quality of evidence that anti-reflux surgery cannot be recommended for chemoprevention for people with Barretts oesophagus.

• #26 Azthena logo with the word Azthena

  https://www.news-medical.net/health/Barretts-Esophagus-Preventing-Progression.aspx

  Preventing the progression of this condition to high-grade dysplasia and cancer is very vital in order to reduce the possible complications as well as improve the survival chance of the patients. […] Treatments to minimize the risk of cell transformation into malignancy are available to patients affected by BE and this can greatly help them from becoming dysplastic. […] Studies also report that the cancer risk for people with BE is lesser in patients who consume aspirin or other anti-inflammatory drugs (for e.g., ibuprofen). […] Another drug called statins also helps in minimizing the risk of cancer; these are used to control high cholesterol levels. […] The first-line treatment for this condition is a surgical procedure to permanently stop the acid reflux action, which is called anti-reflux surgery.

• #27 Current management of Barrett esophagus and esophageal adenocarcinoma | Cleveland Clinic Journal of Medicine

  https://www.ccjm.org/content/86/11/724

  The recommended treatment of dysplasia is endoscopic eradication followed by surveillance endoscopy. […] Chemoprevention is an exciting area of research in preventing progression to adenocarcinoma in patients with Barrett esophagus. […] Aspirin has been shown to prevent development of Barrett esophagus in patients with reflux disease, but more studies are needed to validate those findings. […] Gastroesophageal reflux disease is a primary risk factor for esophageal adenocarcinoma, and gastric acid suppression with PPIs reduces cancer risk. […] PPI therapy is associated with a 71% decrease in the risk of high-grade dysplasia and adenocarcinoma in patients with Barrett esophagus. […] Statins appear promising for chemoprevention, but more study is needed. […] Chemoprevention may be considered in patients with Barrett esophagus and multiple risk factors for adenocarcinoma.

• #28 The future of therapy of Barrett’s esophagus and related cancer: a narrative review – Pilonis – Annals of Esophagus

  https://aoe.amegroups.org/article/view/6025/html

  In keeping with the primary role of inflammation in the etiopathogenesis of BE related neoplasia, use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) has been shown to reduce the incidence of gross DNA abnormalities as well as point mutation linked to cancer development. […] Statins represent another interesting class of drug which might interfere with the cancer development in BE. […] Considering that BE is associated with obesity and metabolic syndrome, it is possible to envisage that in the future a combination of PPI with statins and aspirin, which also reduces the cardiovascular risk, might be the preferred pharmacological treatment of patients with BE. […] An optimal solution would be to limit the treatment to those patients at highest risk to progress to cancer.

• #29 Lifestyle interventions can reduce the risk of Barrett’s esophagus: a systematic review and meta‐analysis of 62 studies involving 250,157 participants

  https://pmc.ncbi.nlm.nih.gov/articles/PMC8335822/

  Lifestyle modifications could reduce the risks of Barrett’s esophagus (BE) and, consequently, esophageal adenocarcinoma. […] We found that smoking, alcohol intake, high levels of body fatness, and less sleep time are associated with Barrett’s esophagus risk. There are statistically significant reduced risks of Barrett’s esophagus with aspirin use and vitamin C intake, folate, and dietary fiber. […] Our analyses demonstrated a significantly increased BE risk associated with smoking, alcohol intake, high BMI, less sleep time, and PPI use. Inversed associations were observed with aspirin use, vitamin C intake, and dietary fiber intake. […] The results demonstrated that smoking is associated with Barrett’s esophagus risk. […] A significant 23% increased risk was observed for highest versus lowest alcohol intake and BE risk.

• #30 Lifestyle interventions can reduce the risk of Barrett’s esophagus: a systematic review and meta‐analysis of 62 studies involving 250,157 participants

  https://pmc.ncbi.nlm.nih.gov/articles/PMC8335822/

  Lifestyle modifications could reduce the risks of Barrett’s esophagus (BE) and, consequently, esophageal adenocarcinoma. […] We found that smoking, alcohol intake, high levels of body fatness, and less sleep time are associated with Barrett’s esophagus risk. There are statistically significant reduced risks of Barrett’s esophagus with aspirin use and vitamin C intake, folate, and dietary fiber. […] Our analyses demonstrated a significantly increased BE risk associated with smoking, alcohol intake, high BMI, less sleep time, and PPI use. Inversed associations were observed with aspirin use, vitamin C intake, and dietary fiber intake. […] The results demonstrated that smoking is associated with Barrett’s esophagus risk. […] A significant 23% increased risk was observed for highest versus lowest alcohol intake and BE risk.

• #31

  https://journals.lww.com/ajg/fulltext/2013/10001/medical_prevention_of_barrett_s_esophagus__effects.20.aspx

  Barrett’s esophagus (BE) is a complication of gastroesophageal reflux disease (GERD) that is a precursor to esophageal adenocarcinoma. […] The usage of both calcium and multivitamins appear to be associated with diminished risk of developing BE. […] The benefit of multivitamins would presumably lie within their antioxidant effect. Calcium may bind bile acids and fatty acids, reducing their proliferative effect on epithelial cells.

• #32 Obeticholic Acid for Prevention in Barrett’s Esophagus | Division of Cancer Prevention

  https://prevention.cancer.gov/clinical-trials/clinical-trials-search/nct04939051

  Obeticholic acid has shown anti-cholestatic, anti-inflammatory and anti-fibrotic effects mediated by FXR activation. […] This chain of events reduces the bile acid exposure in esophagus tissue thereby limiting bile acid induced damage and dysplastic progression.

• #33 Azthena logo with the word Azthena

  https://www.news-medical.net/health/Barretts-Esophagus-Preventing-Progression.aspx

  If the healthcare provider identifies dysplasia in any biopsies, the method of treatment changes depending on the grades of dysplasia. […] If the patient is identified with low-grade dysplasia, the physician recommends tight surveillance with every six to twelve months of ablation or endoscopy. […] If the patient is found with high-grade dysplasia, endoscopic therapies are performed to eradicate the Barrett’s tissues. […] In the case of early cancer, an endoscopic procedure is carried out to destroy the cancer present in the specific part of the cell, and this is followed by surgery or destruction of tissue. […] It is advisable to make close follow-ups by participating in biopsy or endoscopy at one- to two-year intervals. […] Having regular follow-ups even there is no Barrett’s esophagus leftover after treatment would be a wise call.

• #34 Barrett’s Esophagus and GERD: Symptoms and Treatments

  https://www.healthline.com/health/gerd/barretts-esophagus

  Barretts esophagus occurs when the tissue of the esophagus is replaced by tissue more similar to that of the intestinal lining. […] Diagnosis and treatment of GERD may help to prevent Barretts esophagus. […] The goal of endoscopic procedures is to eradicate dysplasia and metaplasia, which effectively reverses Barretts esophagus. […] Regular screening tests can detect cancer at an early stage. Early detection prolongs survival. Detecting and treating precancerous cells may even help prevent cancer.

• #35 Current management of Barrett esophagus and esophageal adenocarcinoma | Cleveland Clinic Journal of Medicine

  https://www.ccjm.org/content/86/11/724

  Barrett esophagus is found in 5% to 15% of patients with gastroesophageal reflux disease and is a precursor of esophageal adenocarcinoma, yet the condition often goes undiagnosed. […] Patients with reflux disease who are male, over age 50, or white, and who smoke or have central obesity or a family history of Barrett esophagus or esophageal adenocarcinoma, should undergo initial screening endoscopy and, if no dysplasia is noted, surveillance endoscopy every 3 to 5 years. […] Chemoprotective agents are being studied to prevent progression to dysplasia in Barrett esophagus. […] Screening is recommended for patients with long-standing reflux symptoms ( 5 years) and 1 or more key risk factors: male sex, age over 50, white race, central obesity, and history of smoking. […] In Barrett esophagus without dysplasia, surveillance endoscopy is recommended every 3 to 5 years to detect dysplasia and early esophageal adenocarcinoma.

• #36 Approaching midlife? Be aware of Barrett’s esophagus, a risk factor for esophageal cancer – Mayo Clinic Comprehensive Cancer Center Blog

  https://cancerblog.mayoclinic.org/2023/04/19/approaching-midlife-be-aware-of-barretts-esophagus-a-risk-factor-for-esophageal-cancer/

  A 2022 study from the University of Florida showed that rates of Barrett’s esophagus, a risk factor for esophageal cancer, may be on the rise in adults ages 45 to 64. […] Dr. East explains what causes Barrett’s esophagus, who is at risk, how it’s diagnosed and treated, and what you can do to reduce your risk of developing the condition: […] If you have three or more of these risk factors, Dr. East says you should talk to your health care professional about a screening endoscopy for Barrett’s esophagus. […] Lifestyle changes to ease symptoms are an important place to start, says Dr. East. „Stop smoking, reduce alcohol, try to lose some weight. These things will reduce reflux and esophageal acid exposure.” […] You can reduce your risk of Barrett’s esophagus and esophageal cancer. „Lifestyle measures that reduce the risk of reflux are key because once Barrett’s esophagus develops, it’s a permanent change unless we use some of the ablation techniques,” says Dr. East.

• #37 New Treatment Guidelines for Barrett’s Esophagus Patients Are Released – Future of Personal Health

  https://www.futureofpersonalhealth.com/digestive-health/new-treatment-guidelines-for-barretts-esophagus-patients-are-released/

  For patients with high-grade dysplasia, AGA recommends endoscopic therapy to remove the abnormal precancerous cells. […] Whats more, when patients are in touch with their healthcare providers, they can take steps to better prevent or manage Barretts esophagus, and thereby lower their risk for dysplasia and esophageal cancer. […] Another takeaway from the new guidelines is that tobacco use and obesity are risk factors for esophageal adenocarcinoma. Therefore, losing weight and quitting smoking can improve clinical outcomes. […] A final takeaway from the guidelines is that patients should be aware of how best to manage acid reflux, which can cause that initial damage to the esophagus. The guidelines note that an optimal treatment plan is one that is well-rounded, including both medication and lifestyle changes.

• #38 Treatment of Barrett’s esophagus: a narrative review – Nesheiwat – Annals of Esophagus

  https://aoe.amegroups.org/article/view/6806/html

  It has been stated and demonstrated in studies that antireflux surgery in combination with endoscopic therapy might prevent progression and possibly regression of dysplastic and metaplastic changes in the esophagus. […] In order to determine whether or not ARS should be employed in effort to alter risk of malignant progression in BE, it would be beneficial for future studies to include a larger population, a longer median follow-up, and involvement of different cohorts. […] All patients with LDG should be on a PPI and undergo surveillance with endoscopy with biopsy within six months of reflux control. […] A 2017 meta-analysis of 2,746 patients studied the risk of disease progression in those with LGD treated with either radiofrequency ablation (RFA) or surveillance endoscopy only. […] In comparison to LGD, the majority of patients with HGD must undergo endoscopic treatment because of its increased risk of progression.

• #39 Barrett’s Esophagus is fully preventable and treatable. The Heartburn Center of South Texas has treatment options.

  https://heartburnmd.com/barretts-esophagus-prevention-treatment/

  If lifestyle changes or medications do not prevent reflux, you may benefit from a procedure called fundoplication to augment the lower esophageal sphincter to prevent acid reflux. […] Following RFA, you will need to continue to control GERD so that normal cells can grow back in the lining of your esophagus. If not controlled, the abnormal lining may reappear.

• #40 Treatment of Barrett’s esophagus: a narrative review – Nesheiwat – Annals of Esophagus

  https://aoe.amegroups.org/article/view/6806/html

  It has been stated and demonstrated in studies that antireflux surgery in combination with endoscopic therapy might prevent progression and possibly regression of dysplastic and metaplastic changes in the esophagus. […] In order to determine whether or not ARS should be employed in effort to alter risk of malignant progression in BE, it would be beneficial for future studies to include a larger population, a longer median follow-up, and involvement of different cohorts. […] All patients with LDG should be on a PPI and undergo surveillance with endoscopy with biopsy within six months of reflux control. […] A 2017 meta-analysis of 2,746 patients studied the risk of disease progression in those with LGD treated with either radiofrequency ablation (RFA) or surveillance endoscopy only. […] In comparison to LGD, the majority of patients with HGD must undergo endoscopic treatment because of its increased risk of progression.

• #41 National Institute for Health and Care Excellence (NICE) guidance on monitoring and management of Barrett’s oesophagus and stage I oesophageal adenocarcinoma | Gut

  https://gut.bmj.com/content/73/6/897

  1.2.2 Do not offer aspirin to people with Barretts oesophagus to prevent progression to oesophageal dysplasia and cancer. […] 1.8.1 Do not offer anti-reflux surgery to people with Barretts oesophagus to prevent progression to dysplasia or cancer. […] The committee agreed that anti-reflux surgery does not offer any advantage over medical treatment with PPIs for progression to dysplasia or cancer. Therefore, the committee agreed, based on the current limited and low quality of evidence that anti-reflux surgery cannot be recommended for chemoprevention for people with Barretts oesophagus.

• #42 Treatment of Barrett’s esophagus: a narrative review – Nesheiwat – Annals of Esophagus

  https://aoe.amegroups.org/article/view/6806/html

  It has been stated and demonstrated in studies that antireflux surgery in combination with endoscopic therapy might prevent progression and possibly regression of dysplastic and metaplastic changes in the esophagus. […] In order to determine whether or not ARS should be employed in effort to alter risk of malignant progression in BE, it would be beneficial for future studies to include a larger population, a longer median follow-up, and involvement of different cohorts. […] All patients with LDG should be on a PPI and undergo surveillance with endoscopy with biopsy within six months of reflux control. […] A 2017 meta-analysis of 2,746 patients studied the risk of disease progression in those with LGD treated with either radiofrequency ablation (RFA) or surveillance endoscopy only. […] In comparison to LGD, the majority of patients with HGD must undergo endoscopic treatment because of its increased risk of progression.

• #43 Understanding Barrett’s Esophagus | The University of Kansas Cancer Center

  https://www.kucancercenter.org/research/transformative-research/beyond-the-bench/2018/understanding-barretts-esophagus

  Prateek Sharma, MD, has dedicated his entire career to better understanding a specific complication that can arise from longstanding acid reflux, a condition now so common that people typically self-treat it with over-the-counter products. […] Patients with Barretts esophagus receive endoscopies every 3 to 5 years to watch for early signs of cancer development. The earlier a suspicious area (dysplasia) in the esophagus is spotted, the better. […] Prioritizing patients by risk is a crucial component of care. Most patients with Barretts esophagus do not progress to cancer; therefore its important to identify those at high risk versus low risk. […] Sharma adds that PIB will change the way Barretts esophagus patients are managed, including eliminating unnecessary, costly procedures for patients with low scores. […] The list of Sharmas contributions to Barretts esophagus goes on, and there are several more collaborations in the pipeline. For him, it is about gaining traction on this precancerous condition and ultimately reducing the incidence of esophageal cancer.

• #44 The future of therapy of Barrett’s esophagus and related cancer: a narrative review – Pilonis – Annals of Esophagus

  https://aoe.amegroups.org/article/view/6025/html

  In the era of genomics research advances in our understanding of molecular mechanisms underlying disease pathogenesis and progression have given significant insight in the potential usefulness of molecular biomarkers to quantify cancer risk. […] Therefore, we can clearly envisage a future scenario whereby a combination of clinical and molecular data will be integrated to generate a risk score to quantify the individual risk of BE-related cancer. […] A biomarker-based risk stratification will be applied to guide management decision and avoid exposing elderly patients to un-necessary risks of endoscopic interventions.

• #45 Molecular Abnormalities and Carcinogenesis in Barrett’s Esophagus: Implications for Cancer Treatment and Prevention

  https://www.mdpi.com/2073-4425/16/3/270

  Antireflux surgery, such as laparoscopic total fundoplication, can be more effective in reducing the risk of progression to cancer. […] However, both chemoprevention and antireflux surgery lack standardized protocols for BE. Choosing the appropriate therapeutic approach requires considering individual factors, such as BE extent, GERD symptoms, risk of complications, and patient preferences. […] By integrating molecular biomarkers into surveillance protocols, clinicians can better stratify patients based on their personalized risk of progression to EAC. […] Advances in molecular biology have revealed numerous genetic and epigenetic alterations associated with BE carcinogenesis, including mutations in TP53, dysregulated microRNAs, and changes in DNA methylation patterns. […] Precision medicine can help identify patients at higher risk of progression, enabling the implementation of personalized interventions that maximize treatment efficacy while minimizing side effects.

• #46 The future of therapy of Barrett’s esophagus and related cancer: a narrative review – Pilonis – Annals of Esophagus

  https://aoe.amegroups.org/article/view/6025/html

  In the era of genomics research advances in our understanding of molecular mechanisms underlying disease pathogenesis and progression have given significant insight in the potential usefulness of molecular biomarkers to quantify cancer risk. […] Therefore, we can clearly envisage a future scenario whereby a combination of clinical and molecular data will be integrated to generate a risk score to quantify the individual risk of BE-related cancer. […] A biomarker-based risk stratification will be applied to guide management decision and avoid exposing elderly patients to un-necessary risks of endoscopic interventions.

• #47 National Institute for Health and Care Excellence (NICE) guidance on monitoring and management of Barrett’s oesophagus and stage I oesophageal adenocarcinoma | Gut

  https://gut.bmj.com/content/73/6/897

  Barretts oesophagus is the only known precursor to oesophageal adenocarcinoma, a cancer with very poor prognosis. The main risk factors for Barretts oesophagus are a history of gastro-oesophageal acid reflux symptoms and obesity. […] Individuals with Barretts oesophagus need to be fully informed about the implications of this diagnosis and the benefits and risks of monitoring strategies. Pharmacological treatments are recommended for control of symptoms, but not for chemoprevention. […] The NICE guideline committee has systematically analysed the evidence on pharmacological, endoscopic and surgical interventions to prevent, monitor and treat individuals with Barretts oesophagus and related early neoplasia and produced the following series of recommendations to support healthcare professionals managing individuals with this condition.

• #48 Barrett’s esophagus | UK Healthcare

  https://ukhealthcare.uky.edu/digestive-health-program/conditions/barretts-esophagus

  You can treat GERD to control your symptoms and feel better. […] If Barrett’s esophagus is suspected, a doctor may want to test the lining of the esophagus now and then to check for cells that may develop into cancer. These tests may include endoscopy and doing a biopsy of any cells that do not look normal. […] If you have Barrett’s esophagus, your doctor may suggest that you have endoscopy on a regular schedule. This lets your doctor check for cell changes and cancer. Your doctor will tell you how often you need this test. […] Go to regular follow-up testing, even if you don’t have symptoms. It helps your doctor watch for signs of more changes that may lead to cancer.

• #49 Barrett’s Oesophagus: Causes, Symptoms, and Treatment

  https://patient.info/digestive-health/acid-reflux-and-oesophagitis/barretts-oesophagus

  In Barrett’s oesophagus the cells that line the lower gullet (oesophagus) are abnormal. […] People with Barrett’s oesophagus have an increased risk of developing cancer of the oesophagus. […] However, you may be advised to have regular endoscopies to detect precancerous changes to the cells in the oesophagus. […] If precancerous changes develop then treatment to remove or destroy the precancerous cells may be advised. […] When you have been diagnosed with Barrett’s oesophagus, you may be advised to have a gastroscopy and biopsy at regular intervals to monitor the condition. This is called surveillance. […] If high-grade dysplasia develops, you may be offered treatment to remove the affected cells from the gullet (oesophagus). […] If you develop high-grade dysplasia or oesophageal cancer, the traditional treatment is to undergo surgery to remove the oesophagus (oesophagectomy).

• #50 New Treatment Guidelines for Barrett’s Esophagus Patients Are Released – Future of Personal Health

  https://www.futureofpersonalhealth.com/digestive-health/new-treatment-guidelines-for-barretts-esophagus-patients-are-released/

  If youre living with Barretts esophagus, a precursor to esophageal cancer, you have a lot of healthcare choices to make. […] The latest guidelines for Barretts esophagus patients address an array of concerns for this population. Among them is how to consider the option of undergoing endoscopic eradication therapy for potential esophageal cancer risk reduction. […] For patients with low-grade dysplasia, it may be appropriate to either remove or monitor the cells. This is a decision doctors and patients should make together after discussing the risks and benefits of treatment. […] A patient-centered approach ensures that treatment decision is made collaboratively, taking into account both the medical evidence and the patients preferences and values. […] Surveillance is a reasonable option for patients who place a higher value on harms and a lower value on the uncertain benefits regarding reduction of esophageal cancer mortality.

• #51 Azthena logo with the word Azthena

  https://www.news-medical.net/health/Barretts-Esophagus-Preventing-Progression.aspx

  It has been reported that centers performing treatments for greater volumes of Barrett’s esophagus and dysplasia patients have attained vast success by making patients avoid progression or surgery of their cancers. […] It is advisable for these patients to be in contact with expert surgeons who can help them with the knowledge of options for both anti-reflux and definitive surgery in the case when medications do not produce effective results.

• #52 What is Barrett’s esophagus? | Roswell Park Comprehensive Cancer Center – Buffalo, NY

  https://www.roswellpark.org/cancertalk/202307/what-barretts-esophagus

  Barretts esophagus can be treated to the point of eradication, which would reverse it all together. […] Medications can prevent it from progressing any further towards cancer. […] The first line management of Barretts esophagus is through proton pump inhibitors, says Dr. Prabhu. These are acid-reducing medications meant to decrease the damage of acid reflux and, as a result, decrease the rate at which Barretts esophagus converts to cancer. […] Through radiofrequency ablation, high amounts of heat are applied to the lining of the esophagus where Barretts is present. The lining that has been subjected to the heat will eventually shed and be replaced by tissue that is not precancerous. […] It is for this reason that it is important to seek out expertise at a center that has the experience and volume of treatment for your disease. […] There are data and guidelines supporting the idea that if you have advanced Barretts esophagus, you should go to a center of excellence where there are multiple specialists involved in your care, says Dr. Prabhu.

• #53 Azthena logo with the word Azthena

  https://www.news-medical.net/health/Barretts-Esophagus-Preventing-Progression.aspx

  It has been reported that centers performing treatments for greater volumes of Barrett’s esophagus and dysplasia patients have attained vast success by making patients avoid progression or surgery of their cancers. […] It is advisable for these patients to be in contact with expert surgeons who can help them with the knowledge of options for both anti-reflux and definitive surgery in the case when medications do not produce effective results.

• #54 Addressing Barrett’s Esophagus: Evaluating Risks and Emphasizing Prevention — Gastro Florida

  https://gastrofl.com/addressing-barretts-esophagus-evaluating-risks-and-emphasizing-prevention/

  While there is no clear-cut method to prevent Barrett’s Esophagus, certain lifestyle changes can reduce one’s risk. […] These include maintaining a healthy weight, avoiding tobacco use, managing GERD symptoms with medication, and limiting alcohol consumption. […] Preventing Barrett’s Esophagus involves controlling acid reflux through lifestyle modifications such as diet changes, weight loss, and quitting smoking. […] Regular endoscopic surveillance for those with known risk factors can lead to early identification and treatment of Barrett’s Esophagus. […] By understanding the risks involved and implementing preventative strategies, individuals can take control of their health and reduce their risk of developing this potentially life-threatening condition. […] Regular screenings and lifestyle interventions are key components in managing Barrett’s Esophagus, emphasizing the importance of proactive measures for better health outcomes. […] A multi-faceted approach, including lifestyle changes, medical management, and regular surveillance, is imperative for at-risk individuals. […] Early detection and intervention are crucial in mitigating the effects of this condition and improving overall outcomes.

• #55 Molecular Abnormalities and Carcinogenesis in Barrett’s Esophagus: Implications for Cancer Treatment and Prevention

  https://www.mdpi.com/2073-4425/16/3/270

  Barrett’s esophagus (BE) is described by the transformation of the normal squamous epithelium into metaplastic columnar epithelium, driven by chronic gastroesophageal reflux disease (GERD). […] Understanding the molecular mechanisms underlying BE carcinogenesis is crucial for improving prevention, surveillance, and treatment strategies. […] Innovations in chemoprevention, such as combining proton pump inhibitors and aspirin, and the potential of antireflux surgery to halt disease progression are promising. […] A deeper understanding of its molecular transformation can enhance surveillance protocols, optimize the management of gastroesophageal reflux inflammation, and refine prevention and therapeutic strategies, ultimately contributing to a reduction in the global burden of EAC. […] Chemoprevention emerges as a promising area in preventing carcinogenesis in BE. The randomized AspECT trial demonstrated that a combination of high-dose proton pump inhibitors (PPIs) and aspirin significantly delayed the development of EAC and high-grade dysplasia in BE patients.

• #56 Research Highlights: Barrett’s Esophagus Translational Research Network (BETRNet) Studies Provide Insights into Prevention and Risk for Esophageal Cancer | Division of Cancer Prevention

  https://prevention.cancer.gov/news-and-events/blog/research-highlights-barretts-esophagus-translational-research-network-betrnet

  Findings from two studies aimed at learning more about preventing the type of esophageal cancer with the fastest growing incidence rate have emerged recently from the Barretts Esophagus Translational Research Network (BETRNet) as it winds down its collaborative activities. […] Researchers hope that learning more about the mechanisms behind the development of Barretts esophagus and esophageal adenocarcinoma will lead to ways to prevent and slow the development of disease. […] As a result, this cranberry chemical compound seems to be a safe, promising dietary constituent for use alone or as an adjuvant to existing therapies to prevent disease progression, the investigators concluded. […] The study findings suggest these genetic defects are critical players in esophageal homeostasis, the investigators wrote, and reveal new insights into how Barretts esophagus and esophageal adenocarcinoma begin.

• #57 Esophageal Cancer Awareness Month: Prevention & Barrett’s Esophagus | Masonic Cancer Center

  https://cancer.umn.edu/mncctn/news/esophageal-cancer-awareness-month-prevention-barretts-esophagus

  Clinical trials are examining what guidelines should be for screening and diagnosis of Barretts esophagus, as well as determining new strategies and procedures for diagnosis that may be less disruptive and uncomfortable. […] Further research is needed to determine which guidelines are most effective and appropriate to screen for both Barretts esophagus and esophageal adenocarcinoma to ensure the best outcomes for patients.

• #58 Addressing Barrett’s Esophagus: Evaluating Risks and Emphasizing Prevention — Gastro Florida

  https://gastrofl.com/addressing-barretts-esophagus-evaluating-risks-and-emphasizing-prevention/

  While there is no clear-cut method to prevent Barrett’s Esophagus, certain lifestyle changes can reduce one’s risk. […] These include maintaining a healthy weight, avoiding tobacco use, managing GERD symptoms with medication, and limiting alcohol consumption. […] Preventing Barrett’s Esophagus involves controlling acid reflux through lifestyle modifications such as diet changes, weight loss, and quitting smoking. […] Regular endoscopic surveillance for those with known risk factors can lead to early identification and treatment of Barrett’s Esophagus. […] By understanding the risks involved and implementing preventative strategies, individuals can take control of their health and reduce their risk of developing this potentially life-threatening condition. […] Regular screenings and lifestyle interventions are key components in managing Barrett’s Esophagus, emphasizing the importance of proactive measures for better health outcomes. […] A multi-faceted approach, including lifestyle changes, medical management, and regular surveillance, is imperative for at-risk individuals. […] Early detection and intervention are crucial in mitigating the effects of this condition and improving overall outcomes.

Zobacz więcej